Skip to main content

Table 3 Comorbidities by ART exposure, in strata of age

From: Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?

Comorbidity

Prevalence by ART exposure in strata of age

50–59

  

 ≥ 60

  

 ≤ 3 years

 > 3 years

aRR

95% CI

 ≤ 3 years

 > 3 years

aRR

95% CI

 

N = 227

N = 757

  

N = 96

N = 314

  

Dyslipidemia

49.8

68.1

1.40

1.22–1.62

58.3

71.3

1.26

1.05–1.52

Hypertension

16.7

27.2

1.61

1.16–2.23

36.5

51.3

1.48

1.10–1.99

Hypovitaminosis D

14.5

27.7

1.77

1.25–2.50

13.5

27.4

2.14

1.26–3.64

Liver disease

13.7

26.4

1.97

1.39–2.79

11.5

13.7

1.20

0.65–2.23

CNS disturbance

15.4

14.5

0.84

0.58–1.21

17.7

12.4

0.64

0.37–1.11

Renal impairment

5.3

8.6

1.48

0.81–2.73

16.7

18.8

1.30

0.74–2.28

Osteopenia/osteoporosis

4.8

11.1

2.02

1.09–3.74

2.1

16.2

7.54

1.87–30.37

Diabetes

7.9

6.8

0.91

0.52–1.58

11.5

13.7

1.28

0.69–2.38

Other CVD

1.8

6.6

2.93

1.06–8.13

15.6

14.3

1.02

0.60–1.73

Obesity

7.0

8.6

1.25

0.73–2.14

3.1

8.3

2.72

0.84–8.79

Epilepsy

2.2

4.8

1.68

0.46–4.30

1.0

4.8

4.24

0.56–32.00

Non-AIDS-related malignancies

2.6

3.3

1.17

0.48–2.89

3.1

4.8

1.42

0.41–4.88

Lung disease

1.8

2.2

0.71

0.24–2.10

5.2

3.5

0.68

0.24–1.94

Multimorbidity

43.2

62.1

1.41

1.19–1.65

57.3

72.9

1.30

1.08–1.57

  1. ART antiretroviral treatment, CI confidence interval, CNS central nervous system, CVD cardiovascular disease, aRR adjusted rate ratio